138 related articles for article (PubMed ID: 29254661)
1. Low reported taste function is associated with low preference for high protein products in advanced oesophagogastric cancer patients undergoing palliative chemotherapy.
de Vries YC; Boesveldt S; Kampman E; de Graaf C; Winkels RM; van Laarhoven HWM
Clin Nutr; 2019 Feb; 38(1):472-475. PubMed ID: 29254661
[TBL] [Abstract][Full Text] [Related]
2. The impact of chemosensory and food-related changes in patients with advanced oesophagogastric cancer treated with capecitabine and oxaliplatin: a qualitative study.
de Vries YC; Helmich E; Karsten MD; Boesveldt S; Winkels RM; van Laarhoven HW
Support Care Cancer; 2016 Jul; 24(7):3119-26. PubMed ID: 26919988
[TBL] [Abstract][Full Text] [Related]
3. Chemosensory perception and food preferences in colorectal cancer patients undergoing adjuvant chemotherapy.
Postma EM; Kok DE; de Graaf C; Kampman E; Boesveldt S
Clin Nutr ESPEN; 2020 Dec; 40():242-251. PubMed ID: 33183544
[TBL] [Abstract][Full Text] [Related]
4. ALTERTASTE: improving food pleasure and intake of oncology patients receiving chemotherapy.
Spinelli S; Mini E; Monteleone E; Angiolini C; Roviello G
Future Oncol; 2021 Jul; 17(20):2573-2579. PubMed ID: 33858202
[TBL] [Abstract][Full Text] [Related]
5. Changes in taste and smell function, dietary intake, food preference, and body composition in testicular cancer patients treated with cisplatin-based chemotherapy.
IJpma I; Renken RJ; Gietema JA; Slart RHJA; Mensink MGJ; Lefrandt JD; Ter Horst GJ; Reyners AKL
Clin Nutr; 2017 Dec; 36(6):1642-1648. PubMed ID: 27836309
[TBL] [Abstract][Full Text] [Related]
6. Chemosensory Changes from Cancer Treatment and Their Effects on Patients' Food Behavior: A Scoping Review.
Nolden AA; Hwang LD; Boltong A; Reed DR
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31554217
[TBL] [Abstract][Full Text] [Related]
7. The palatability of milk-based and non-milk-based nutritional supplements in gastrointestinal cancer and the effect of chemotherapy.
Rahemtulla Z; Baldwin C; Spiro A; McGough C; Norman AR; Frost G; Cunningham D; Andreyev HJ
Clin Nutr; 2005 Dec; 24(6):1029-37. PubMed ID: 16185789
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial.
Eltweri AM; Thomas AL; Chung WY; Morgan B; Thompson J; Dennison AR; Bowrey DJ
Anticancer Res; 2019 Feb; 39(2):853-861. PubMed ID: 30711967
[TBL] [Abstract][Full Text] [Related]
9. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study.
Bernhardson BM; Tishelman C; Rutqvist LE
J Pain Symptom Manage; 2007 Oct; 34(4):403-12. PubMed ID: 17616338
[TBL] [Abstract][Full Text] [Related]
10. Taste and smell function in testicular cancer survivors treated with cisplatin-based chemotherapy in relation to dietary intake, food preference, and body composition.
IJpma I; Renken RJ; Gietema JA; Slart RH; Mensink MG; Lefrandt JD; Ter Horst GJ; Reyners AK
Appetite; 2016 Oct; 105():392-9. PubMed ID: 27298084
[TBL] [Abstract][Full Text] [Related]
11. Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment.
Amézaga J; Alfaro B; Ríos Y; Larraioz A; Ugartemendia G; Urruticoechea A; Tueros I
Support Care Cancer; 2018 Dec; 26(12):4077-4086. PubMed ID: 29855774
[TBL] [Abstract][Full Text] [Related]
12. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer.
Hutton JL; Baracos VE; Wismer WV
J Pain Symptom Manage; 2007 Feb; 33(2):156-65. PubMed ID: 17280921
[TBL] [Abstract][Full Text] [Related]
13. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients.
Schiffman SS; Sattely-Miller EA; Taylor EL; Graham BG; Landerman LR; Zervakis J; Campagna LK; Cohen HJ; Blackwell S; Garst JL
J Nutr Health Aging; 2007; 11(5):439-54. PubMed ID: 17657366
[TBL] [Abstract][Full Text] [Related]
14. Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in human epidermal growth factor receptor 2-positive advanced oesophagogastric cancer: A meta-analysis.
Ter Veer E; Creemers A; de Waal L; van Oijen MGH; van Laarhoven HWM
Int J Cancer; 2018 Jul; 143(2):438-448. PubMed ID: 29451302
[TBL] [Abstract][Full Text] [Related]
15. A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes.
Boltong A; Aranda S; Keast R; Wynne R; Francis PA; Chirgwin J; Gough K
PLoS One; 2014; 9(7):e103512. PubMed ID: 25078776
[TBL] [Abstract][Full Text] [Related]
16. Chemosensory changes during chemotherapy.
Mohamed MAE; Ibrahim NMI; Elezaby HH; Shehab MS
Int J Palliat Nurs; 2024 Mar; 30(3):147-155. PubMed ID: 38517848
[TBL] [Abstract][Full Text] [Related]
17. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
[TBL] [Abstract][Full Text] [Related]
18. Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment.
Boltong A; Keast R; Aranda S
Support Care Cancer; 2012 Nov; 20(11):2765-74. PubMed ID: 22350644
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial.
Ochenduszko S; Puskulluoglu M; Konopka K; Fijorek K; Urbanczyk K; Budzynski A; Matlok M; Lazar A; Sinczak-Kuta A; Pedziwiatr M; Krzemieniecki K
Med Oncol; 2015 Oct; 32(10):242. PubMed ID: 26354521
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy alters subjective senses of taste and smell but not dietary patterns in Japanese lung cancer patients.
Yoshimoto N; Inagaki M; Sekiguchi Y; Tomishima Y; Masuko K
Support Care Cancer; 2020 Apr; 28(4):1667-1674. PubMed ID: 31286236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
